Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Schering-Plough patents new tachykinin NK1/NK2 antagonists

Aug. 14, 1998

More PDE IVA inhibitors in the pipeline at Kyowa Hakko

Aug. 13, 1998

Menarini's NK1 antagonist MEN-11467 shows promising antiasthmatic activity

Aug. 12, 1998

Antiinflammatory cytokine modulators described by Amgen

Aug. 12, 1998

Kyowa Hakko discovers PDE IVA inhibitors for a range of potential indications

Aug. 12, 1998

RS-601, a dual-action TxA2/LTD4 antagonist with potent antiasthmatic effects

Aug. 11, 1998

Byk Gulden researchers synthesize PDE IV inhibitors with broad therapeutic potential

Aug. 11, 1998

New antiasthmatic PDE IV inhibitors revealed by Celltech

Aug. 10, 1998

PDE inhibitors from Kyorin useful as bronchodilators

July 31, 1998

Bronchodilators with a pyrrolopyrazolopyrimidine structure patented by Pola

July 29, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...